Definitive Healthcare (NASDAQ:DH) Price Target Cut to $2.00 by Analysts at Stephens

Definitive Healthcare (NASDAQ:DH) had its price objective cut by Stephens from $3.00 to $2.00 in a report published on Friday,Benzinga reports. They currently have an equal weight rating on the stock.

DH has been the subject of several other reports. Canaccord Genuity Group reduced their price target on Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Barclays decreased their target price on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating for the company in a research note on Monday, December 8th. William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a report on Thursday, November 6th. Wall Street Zen cut shares of Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, December 28th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Definitive Healthcare has an average rating of “Hold” and a consensus target price of $3.66.

Definitive Healthcare Trading Down 15.2%

DH traded down $0.21 during trading on Friday, reaching $1.19. 240,918 shares of the company’s stock were exchanged, compared to its average volume of 369,506. The company’s fifty day moving average price is $2.21 and its 200-day moving average price is $2.89. The firm has a market capitalization of $167.79 million, a PE ratio of -0.72 and a beta of 1.59. Definitive Healthcare has a fifty-two week low of $1.14 and a fifty-two week high of $4.70. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.60 and a current ratio of 1.60.

Hedge Funds Weigh In On Definitive Healthcare

Several large investors have recently modified their holdings of DH. State of Alaska Department of Revenue grew its stake in Definitive Healthcare by 109.3% in the 4th quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after buying an additional 5,970 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Definitive Healthcare in the 2nd quarter valued at $32,000. Schonfeld Strategic Advisors LLC bought a new position in Definitive Healthcare during the 4th quarter worth $35,000. Savant Capital LLC bought a new stake in shares of Definitive Healthcare in the second quarter valued at about $45,000. Finally, SG Americas Securities LLC acquired a new position in shares of Definitive Healthcare in the fourth quarter valued at about $46,000. 98.67% of the stock is owned by institutional investors.

Key Headlines Impacting Definitive Healthcare

Here are the key news stories impacting Definitive Healthcare this week:

• Positive Sentiment: Balance-sheet improvement — cash and cash equivalents rose to ~$163.6M (up ~55% YoY) and total liabilities fell materially, which supports liquidity and runway. Read More.
• Neutral Sentiment: Revenue was roughly in line with forecasts — Q4 revenue reported at ~$61.5M, slightly above consensus, and adjusted EPS of $0.06 matched analysts’ estimates. This limited upside from the print itself. Read More.
• Neutral Sentiment: Analyst sentiment remains muted — brokerages’ average recommendation is “Hold,” implying limited near-term analyst-driven upside. Read More.
• Negative Sentiment: Guidance cut — management lowered Q1 and FY2026 guidance (Q1 EPS guide ~ $0.03 vs. ~$0.05 consensus; FY EPS guide $0.14–$0.17 vs. ~$0.21 consensus; revenue ranges also below Street), which is the principal driver of the stock’s weakness. Read More.
• Negative Sentiment: GAAP profitability and operating cash flow concerns plus institutional selling — reports show a wider operating loss, a GAAP net loss/diluted EPS weakness (reported by third parties) and a sharp drop in cash from operations; several large institutional holders trimmed positions. These factors amplify downside risk. Read More.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.